Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders

T. Tashi, N. Scott Reading, T. Wuren, X. Zhang, LG. Moore, H. Hu, F. Tang, A. Shestakova, F. Lorenzo, T. Burjanivova, P. Koul, P. Guchhait, CT. Wittwer, CG. Julian, B. Shah, CD. Huff, VR. Gordeuk, JT. Prchal, R. Ge,

. 2017 ; 95 (6) : 665-670. [pub] 20170223

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010782
E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

Odkazy

PubMed 28233034
DOI 10.1007/s00109-017-1519-3
Knihovny.cz E-zdroje

Tibetans have lived at high altitude for generations and are thought to be genetically adapted to hypoxic environments. Most are protected from hypoxia-induced polycythemia, and a haplotype of EPAS1, encoding hypoxia-inducible factor (HIF-2α), has been associated with lower hemoglobin levels. We earlier reported a Tibetan-specific EGLN1 haplotype encoding PHD2 which abrogates HIF augmentation in hypoxia. We genotyped 347 Tibetan individuals from varying altitudes for both the Tibetan-specific EGLN1 haplotype and 10 candidate SNPs in the EPAS1 haplotype and correlated their association with hemoglobin levels. The effect of the EGLN1 haplotype on hemoglobin exhibited age dependency at low altitude, while at higher altitudes, it showed a trend to lower hemoglobin levels in the presence of the Tibetan-selected EPAS1 rs142764723 C/C allele. The observed gene-environment and gene-gene interactions and the moderate effect of the EGLN1 and EPAS1 haplotypes on hemoglobin indicate that other modifiers exist. It remains to be determined whether a blunting of erythropoiesis or other physiological consequences of HIF downregulation are the primary drivers of these genetic adaptations among Tibetans. KEY MESSAGE: Most Tibetans are protected from polycythemia while living in high altitude. An EGLN1 co-adapted haplotype, EGLN1 c.12C>G, c.380G>C is uniquely Tibetan. The Tibetan EPAS1 haplotype has introgressed from the Denisovan genome. While EGLN1 and EPAS1 genotypes lower Hb, this study indicates additional Hb modifiers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010782
003      
CZ-PrNML
005      
20190125095617.0
007      
ta
008      
180404s2017 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00109-017-1519-3 $2 doi
035    __
$a (PubMed)28233034
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Tashi, Tsewang $u Division of Hematology, University of Utah, Salt Lake City, UT, USA.
245    10
$a Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders / $c T. Tashi, N. Scott Reading, T. Wuren, X. Zhang, LG. Moore, H. Hu, F. Tang, A. Shestakova, F. Lorenzo, T. Burjanivova, P. Koul, P. Guchhait, CT. Wittwer, CG. Julian, B. Shah, CD. Huff, VR. Gordeuk, JT. Prchal, R. Ge,
520    9_
$a Tibetans have lived at high altitude for generations and are thought to be genetically adapted to hypoxic environments. Most are protected from hypoxia-induced polycythemia, and a haplotype of EPAS1, encoding hypoxia-inducible factor (HIF-2α), has been associated with lower hemoglobin levels. We earlier reported a Tibetan-specific EGLN1 haplotype encoding PHD2 which abrogates HIF augmentation in hypoxia. We genotyped 347 Tibetan individuals from varying altitudes for both the Tibetan-specific EGLN1 haplotype and 10 candidate SNPs in the EPAS1 haplotype and correlated their association with hemoglobin levels. The effect of the EGLN1 haplotype on hemoglobin exhibited age dependency at low altitude, while at higher altitudes, it showed a trend to lower hemoglobin levels in the presence of the Tibetan-selected EPAS1 rs142764723 C/C allele. The observed gene-environment and gene-gene interactions and the moderate effect of the EGLN1 and EPAS1 haplotypes on hemoglobin indicate that other modifiers exist. It remains to be determined whether a blunting of erythropoiesis or other physiological consequences of HIF downregulation are the primary drivers of these genetic adaptations among Tibetans. KEY MESSAGE: Most Tibetans are protected from polycythemia while living in high altitude. An EGLN1 co-adapted haplotype, EGLN1 c.12C>G, c.380G>C is uniquely Tibetan. The Tibetan EPAS1 haplotype has introgressed from the Denisovan genome. While EGLN1 and EPAS1 genotypes lower Hb, this study indicates additional Hb modifiers.
650    _2
$a aklimatizace $x genetika $7 D000064
650    _2
$a dospělí $7 D000328
650    _2
$a nadmořská výška $7 D000531
650    _2
$a Asijci $x genetika $7 D044466
650    _2
$a transkripční faktory bHLH $x genetika $7 D051792
650    _2
$a erythropoetin $x krev $7 D004921
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ferritiny $x krev $7 D005293
650    _2
$a interakce genů a prostředí $7 D059647
650    _2
$a haplotypy $7 D006239
650    _2
$a hemoglobiny $x analýza $7 D006454
650    _2
$a lidé $7 D006801
650    _2
$a prolyl-4-hydroxylasy HIF $x genetika $7 D064799
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a Tibet $7 D018609
655    _2
$a časopisecké články $7 D016428
700    1_
$a Scott Reading, N $u Division of Hematology, University of Utah, Salt Lake City, UT, USA. Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.
700    1_
$a Wuren, Tanna $u Research Center for High-Altitude Medicine, Qinghai University, Xining, China.
700    1_
$a Zhang, Xu $u Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
700    1_
$a Moore, Lorna G $u Departments of Medicine and Obstetrics/Gynecology, University of Colorado Denver, Aurora, CO, USA.
700    1_
$a Hu, Hao $u MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
700    1_
$a Tang, Feng $u Research Center for High-Altitude Medicine, Qinghai University, Xining, China.
700    1_
$a Shestakova, Anna $u Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.
700    1_
$a Lorenzo, Felipe $u Division of Hematology, University of Utah, Salt Lake City, UT, USA.
700    1_
$a Burjanivova, Tatiana $u Division of Hematology, University of Utah, Salt Lake City, UT, USA. Department of Molecular Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
700    1_
$a Koul, Parvaiz $u Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
700    1_
$a Guchhait, Prasenjit $u Regional Centre for Biotechnology, Faridabad, Haryana, India.
700    1_
$a Wittwer, C. $d 1955- $7 xx0231641 $u Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.
700    1_
$a Julian, Colleen G $u Departments of Medicine and Obstetrics/Gynecology, University of Colorado Denver, Aurora, CO, USA.
700    1_
$a Shah, Binal $u Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
700    1_
$a Huff, Chad D $u MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
700    1_
$a Gordeuk, Victor R $u Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
700    1_
$a Prchal, Josef T $u Division of Hematology, University of Utah, Salt Lake City, UT, USA. josef.prchal@hsc.utah.edu. Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA. josef.prchal@hsc.utah.edu. Department of Pathophysiology and 1st Department of Medicine, 1st Faculty Medicine, Charles University in Prague, Prague, Czech Republic. josef.prchal@hsc.utah.edu. Hematology, SOM 5C310, University of Utah School of Medicine, Salt Lake City, UT, 84132-2408, USA. josef.prchal@hsc.utah.edu.
700    1_
$a Ge, RiLi $u Research Center for High-Altitude Medicine, Qinghai University, Xining, China. geriligao@hotmail.com.
773    0_
$w MED00002812 $t Journal of molecular medicine (Berlin, Germany) $x 1432-1440 $g Roč. 95, č. 6 (2017), s. 665-670
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28233034 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20190125095840 $b ABA008
999    __
$a ok $b bmc $g 1288267 $s 1007594
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 95 $c 6 $d 665-670 $e 20170223 $i 1432-1440 $m Journal of molecular medicine $n J Mol Med $x MED00002812
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace